Publication Name	World Journal of Hepatology
Manuscript ID	16148
Country	China

Received	2014-12-29 19:21
Peer-Review Started	2014-12-30 15:39
To Make the First Decision	2015-01-20 13:29
Return for Revision	2015-02-02 20:45
Revised	2015-02-03 07:38
Second Decision	2015-08-03 15:04
Accepted by Journal Editor-in-Chief	2015-08-04 15:47
Accepted by Executive Editor-in-Chief	2015-08-11 15:07
Articles in Press	2015-08-11 15:07
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2015-08-21 15:28
Publish the Manuscript Online	2015-08-29 17:10

ISSN	1948-5182 (online)
Open Access	This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright	© The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Editorial
Article Title	Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet
Manuscript Source	Invited Manuscript
All Author List	Grace Lai-Hung Wong
Funding Agency and Grant Number
Corresponding Author	Grace Lai-Hung Wong, MD, Department of Medicine and Therapeutics, 9/F Prince of Wales Hospital, the Chinese University of Hong Kong, 30-32 Ngan Shing Street, Shatin, Hong Kong, China. wonglaihung@cuhk.edu.hk
Key Words	Antiviral therapy; Biomarkers; Hepatocellular carcinoma; Hepatocellular carcinoma risk scores; Liver stiffness measure; Surveillance program
Core Tip	The key components of an optimal surveillance program include an accurate tumor biomarker and optimal surveillance interval for hepatocellular carcinoma (HCC). Cancer-associated genome-wide hypomethylation and copy number aberrations by plasma DNA bisulfite sequencing are two promising genomic markers of HCC. Risk prediction by HCC risk scores may assist prognostication and to decide the optimal surveillance interval.
Publish Date	2015-08-29 17:10
Citation	Wong GLH. Optimal surveillance program for hepatocellular carcinoma - getting ready, but not yet. World J Hepatol 2015; 7(18): 2133-2135
URL	http://www.wjgnet.com/1948-5182/full/v7/i18/2133.htm
DOI	http://dx.doi.org/10.4254/wjh.v7.i18.2133

Full Article (PDF)	WJH-7-2133.pdf
Full Article (Word)	WJH-7-2133.doc
Manuscript File	16148-Review.docx
Answering Reviewers	16148-Answering reviewers.pdf
Audio Core Tip	16148-Audio core tip.mp3
Conflict-of-Interest Disclosure Form	16148-Conflict-of-interest statement.pdf
Copyright License Agreement	16148-Copyright assignment.pdf
Non-Native Speakers of English Editing Certificate	Editing_Certificate_20141229183832.docx
Peer-review Report	16148-Peer-review(s).pdf
Journal Editor-in-Chief Review Report	16148-Journal editor-in-chief review report.pdf
Scientific Misconduct Check	16148-Scientific misconduct check.pdf
Scientific Editor Work List	16148-Scientific editor work list.pdf